vimarsana.com

மருத்துவ மருத்துவர் கட்டணம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Telehealth – Here to Stay (At Least for Now): CMS Considers Permanent Expansion of Telehealth Services in Proposed Rule | BakerHostetler

Telehealth – Here to Stay (At Least for Now): CMS Considers Permanent Expansion of Telehealth Services in Proposed Rule | BakerHostetler
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

INVESTOR ALERT: Law Offices of Howard G Smith Announces Investigation of iRhythm Technologies, Inc (IRTC) on Behalf of Investors

Posted on 153 Law Offices of Howard G. Smith announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company’s possible violations of federal securities laws. iRhythm Technologies provides wearable biosensor devices to detect and monitor heart arrhythmias. On December 2, 2020, iRhythm issued a press release stating that new Centers for Medicare and Medicaid Services (CMS) physician fee guidelines would change how payments for its Zio XT remote cardiac monitoring services would be calculated. On this news, the Company’s stock price dropped approximately 20%. On January 29, 2021, a research analyst from Baird indicated that the recent publication by Novitas Solutions, a Medicare Administrative Contractor, of reimbursement rates for CPT codes are “way lower than” those published in the Medicare Physician Fee Schedule.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of iRhythm Technologies, Inc (IRTC) on Behalf of Investors

Posted on 20112 Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your iRhythm investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/irhythm-technologies-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.